SULAY AMPARO TOVAR CARRO

Sulay Amparo Tovar Carro is a Professor in the Department of Physiology at the University of Santiago de Compostela, affiliated with the Faculty of Pharmacy and the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS). She holds a PhD from the same university (2007), focusing on metabolic interactions involving PYY, Adiponectin, Resistin, and Ghrelin. Her research integrates molecular metabolism, endocrine regulation, and nanomedicine, with a focus on energy homeostasis, obesity, and drug delivery systems.

Key areas of study include hormonal signaling pathways (e.g., ghrelin, LEAP-2, leptin), metabolic diseases (non-alcoholic steatohepatitis, NASH), and innovative drug delivery strategies using nanoparticles and biomimetic technologies. She has explored the role of NEDDylation in aging and liver function, as well as neuropsychological links between endocrine factors and gambling disorder severity. Her work bridges basic physiology with translational applications, including oral peptide delivery systems for insulin and other therapeutic peptides.

Research groups include MetaMol (Molecular Metabolism) and GIBIOMED (Biomedical Research Group). Despite extensive publications, no scientific awards are explicitly mentioned. Her collaborative projects involve pharmaceutical formulation development and molecular mechanisms underlying metabolic disorders. Current efforts emphasize neuronal circuits regulating skeletal muscle metabolism and hypothalamic control of energy expenditure.